Legal News

Pfizer Settles Class Action Suit for $486 Million
Download PDF
1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)
Loading...

NEW YORK - JANUARY 26:  A Pfizer sign hangs on the outside of their headquarters after a news conference discussing the planned merger of Pfizer and Wyeth January 26, 2009 in New York City. Pfizer plans to acquire Wyeth for $68 billion creating the world's largest biopharmaceutical company.  (Photo by Mario Tama/Getty Images)

Photo courtesy of U.S. News. 

Summary: Pfizer has agreed to pay $486 million to settle a class action lawsuit with investors. 

After over a decade of fighting a lawsuit, drug giant Pfizer said on Tuesday that it has agreed to pay $486 million to settle. The company was sued by investors in 2004 for allegedly failing to disclose the dangers of its bestselling pain relievers, Celebrex and Bextra.

  
What
Where


The settlement resolves accusations from investors who claimed Pfizer failed to disclose that Celebrex and Bextra could increase a patient’s risk of heart attack or stroke. The investors who owned stock between October 31, 2001 to October 19, 2005 filed a class action lawsuit, and they said that Pfizer had concealed related tests that dated back as early as 1998.

Rival company Merck withdrew a similar drug because of heart risks, which triggered an inquiry into Bextra and Celebrex. The investors said that when Pfizer’s tests finally were made public, the prescription drugs’ stock plummeted by roughly $70 billion.

In the end, Pfizer pulled Bextra from the market in the United States.

Get JD Journal in Your Mail

Subscribe to our FREE daily news alerts and get the latest updates on the most happening events in the legal, business, and celebrity world. You also get your daily dose of humor and entertainment!!




In September 2009, Pfizer settled with the federal government for $2.3 billion after a probe into the marketing of its drugs.

A spokesman for Pfizer said that the settlement is not an admission of guilt.



“This resolution reflects a desire by the company to avoid the distraction of continued litigation and focus on the needs of patients and prescribers,” Pfizer said.

Plaintiffs had sued Pfizer and its executives, including former Chief Executive Henry McKinnell.

What do you think of Pfizer and this case? Let us know in the comments below.

Source: Reuters



 

Interesting Legal Sites You May Like


BCG FEATURED JOB

Locations:

Keyword:



Search Now

General Municipal Law Attorney with land use experience

USA-CA-Oakland

Oakland office of our client seeks general municipal law attorney with experience advising public ag...

Apply Now

Senior Land Use Attorney with experience

USA-CA-San Francisco

San Francisco office of our client seeks senior land use attorney with 7+ years of experience. The c...

Apply Now

Immigration Attorney with portable business

USA-VA-McLean

McLean office is seeking an immigration attorney with $500,000+ in portable business.

Apply Now

Commercial Litigation Attorney with 4+ years of experience

USA-IL-Chicago

Chicago office of our client seeks commercial litigation attorney with 4+ years of experience. The c...

Apply Now

RELEVANT JOBS

Litigation Associate (Junior to Mid-Level) - Medical Malpractice - Garden City, NY

USA-NY-Garden City

Defense firm seeking junior to mid-level associate for Garden City office to fill Medical Malpractic...

Apply now

CIVIL LITIGATION ATTORNEY - Employment

USA-CA-Fresno

Lang, Richert & Patch a Fresno area AV-rated law firm located in the highly desirable Fig Garden Fin...

Apply now

ASSOCIATE ATTORNEY

USA-TX-Houston

INSURANCE DEFENSE / TRANSPORTATION LITIGATION Law firm located in North Houston seeking an associ...

Apply now

Hotline & Training Managing Attorney (IMMIGRATION)

USA-NY-New York City

Summary: The Hotline & Training Services Managing Attorney will guide, develop, and supervise the Ho...

Apply now

Most Popular

SEARCH IN ARCHIVE

To Top